Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luminespib +/- Bortezomib in Relapsed/Refractory Multiple Myeloma
NCT00708292Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of Luminespib in multiple myeloma (MM), sponsored by Novartis. Started Jul 2008; status: completed.
02
Drugs
Luminespib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00708292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00708292.